Ingenium Pharmaceuticals and Tuebingen Link up on Eye Research | GenomeWeb

NEW YORK, April 16 - Ingenium Pharmaceuticals and the molecular genetics laboratory of the University Eye Hospital of Tuebingen, Germany, today announced a research collaboration to create animal models with defined gene alterations for research into the genes related to eye diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.